SOBRsafe Adds Corporate Strategist and Governance Veteran Kris Pederson to Board of Directors
SOBRsafe (NASDAQ: SOBR) has appointed Kris Pederson to its Board of Directors, effective May 1, 2025. Pederson, a former EY partner who led the firm's Center for Board Matters and Americas Strategy Consulting practice, brings 30 years of experience in management consulting, auditing, and corporate governance. She previously held leadership positions at IBM and PriceWaterhouseCoopers.
Additionally, the company appointed Dr. Benjamin Sanchez as Scientific Advisor in February 2025. Dr. Sanchez, an Associate Professor at the University of Illinois Chicago, will focus on accelerating non-dilutive federal funding, licensing, and strengthening relationships with clinical research organizations for alcohol detection testing.
SOBRsafe (NASDAQ: SOBR) ha nominato Kris Pederson nel suo Consiglio di Amministrazione, con effetto dal 1° maggio 2025. Pederson, ex partner di EY che ha guidato il Center for Board Matters e la pratica di Strategy Consulting per le Americhe, vanta 30 anni di esperienza nella consulenza gestionale, revisione contabile e governance aziendale. In precedenza ha ricoperto ruoli dirigenziali presso IBM e PriceWaterhouseCoopers.
Inoltre, la società ha nominato Dr. Benjamin Sanchez come Consulente Scientifico a febbraio 2025. Il Dr. Sanchez, Professore Associato presso l'Università di Illinois Chicago, si concentrerà sull'accelerazione dei finanziamenti federali non diluitivi, sulle licenze e sul rafforzamento delle relazioni con organizzazioni di ricerca clinica per i test di rilevazione dell'alcol.
SOBRsafe (NASDAQ: SOBR) ha nombrado a Kris Pederson en su Junta Directiva, con efecto a partir del 1 de mayo de 2025. Pederson, ex socia de EY que dirigió el Center for Board Matters y la práctica de Consultoría Estratégica para las Américas, aporta 30 años de experiencia en consultoría de gestión, auditoría y gobernanza corporativa. Anteriormente ocupó cargos de liderazgo en IBM y PriceWaterhouseCoopers.
Además, la compañía nombró a Dr. Benjamin Sanchez como Asesor Científico en febrero de 2025. El Dr. Sanchez, Profesor Asociado en la Universidad de Illinois Chicago, se enfocará en acelerar la financiación federal no dilutiva, las licencias y fortalecer las relaciones con organizaciones de investigación clínica para pruebas de detección de alcohol.
SOBRsafe (NASDAQ: SOBR)는 2025년 5월 1일부로 Kris Pederson을 이사회 멤버로 임명했습니다. Pederson은 EY의 전 파트너로서 회사의 이사회 문제 센터와 미주 전략 컨설팅 부문을 이끌었으며, 경영 컨설팅, 감사 및 기업 지배구조 분야에서 30년의 경력을 보유하고 있습니다. 이전에는 IBM과 PriceWaterhouseCoopers에서 리더십 직책을 맡았습니다.
또한, 회사는 2025년 2월에 Dr. Benjamin Sanchez를 과학 자문으로 임명했습니다. 일리노이 대학교 시카고 캠퍼스의 부교수인 Sanchez 박사는 비희석 연방 자금 조달 가속화, 라이선스 및 알코올 감지 테스트를 위한 임상 연구 기관과의 관계 강화에 주력할 예정입니다.
SOBRsafe (NASDAQ : SOBR) a nommé Kris Pederson au sein de son conseil d'administration, à compter du 1er mai 2025. Pederson, ancienne associée chez EY ayant dirigé le Center for Board Matters et la pratique de conseil en stratégie pour les Amériques, possède 30 ans d'expérience en conseil en gestion, audit et gouvernance d'entreprise. Elle a auparavant occupé des postes de direction chez IBM et PriceWaterhouseCoopers.
Par ailleurs, la société a nommé Dr Benjamin Sanchez conseiller scientifique en février 2025. Dr Sanchez, professeur associé à l'Université de l'Illinois à Chicago, se concentrera sur l'accélération du financement fédéral non dilutif, la gestion des licences et le renforcement des relations avec les organisations de recherche clinique pour les tests de détection d'alcool.
SOBRsafe (NASDAQ: SOBR) hat Kris Pederson mit Wirkung zum 1. Mai 2025 in seinen Vorstand berufen. Pederson, eine ehemalige EY-Partnerin, die das Center for Board Matters und die Strategy Consulting Praxis für Amerika leitete, bringt 30 Jahre Erfahrung in Managementberatung, Wirtschaftsprüfung und Unternehmensführung mit. Zuvor hatte sie Führungspositionen bei IBM und PriceWaterhouseCoopers inne.
Zusätzlich ernannte das Unternehmen im Februar 2025 Dr. Benjamin Sanchez zum Wissenschaftlichen Berater. Dr. Sanchez, Associate Professor an der University of Illinois Chicago, wird sich darauf konzentrieren, nicht verwässernde Bundesmittel zu beschleunigen, Lizenzen zu vergeben und die Beziehungen zu klinischen Forschungsorganisationen im Bereich Alkoholtestung zu stärken.
- Addition of highly experienced board member with extensive governance and strategic consulting background
- Appointment of scientific advisor with expertise in bioimpedance technologies and digital health systems
- Potential for accelerated federal funding and clinical research partnerships through new appointments
- None.
Appointed Dr. Benjamin Sanchez as a Scientific Advisor
DENVER, CO / ACCESS Newswire / May 13, 2025 / SOBR Safe, Inc. (NASDAQ:SOBR) ("SOBRsafe" or the "Company"), the leader in next-generation alcohol detection technology, has appointed Kris Pederson to its Board of Directors (the "Board"), effective May 1, 2025. Ms. Pederson will also serve as chairperson of the Company's Nominating and Corporate Governance Committee.
Kris Pederson is a nationally recognized corporate director bringing 30 years of management consulting, auditing, financial analysis and corporate board experience. In her tenure as a former partner at the leading global professional services firm, EY, she led the firm's Center for Board Matters and prior, the EY Americas Strategy Consulting practice, focusing on strategy definition, digital transformation, risk management, mergers and acquisitions governance, and board performance. She also spearheaded strategic transformation practices and several global management consulting practices as a Vice President and Partner at IBM (NYSE: IBM), a leading provider of global hybrid cloud and AI, and consulting expertise. And before that, served as a strategy partner at PriceWaterhouseCoopers, another of the Big 4 professional services firms, similar to EY.
Ms. Pederson has been recognized by the National Association of Corporate Directors as a leading governance professional and was honored with Consulting Magazine's Lifetime Achievement Award and included among their Top 25 Consultants. She holds a BA from UCLA and an MBA from Harvard Business School.
"Kris' appointment brings a valuable combination of governance, strategic consulting, and operational leadership to our Board of Directors," said SOBRsafe Chairman and CEO David Gandini. "Her insights into digital innovation and strategic execution will be a critical asset as we continue to scale and refine the SOBRsafe brand, positioning us for long-term sustainable growth."
"SOBRsafe's technology is addressing the pressing need for preventative safety solutions in today's workplaces and communities," said Kris Pederson. "The Company's proactive approach to accountability and prevention aligns with where governance and technology must intersect today, and I look forward to helping guide SOBRsafe's continued evolution and impact."
In addition to joining the SOBRsafe Board, Kris currently serves on the NASDAQ Governance Advisory Council, the National Association of Corporate Directors (NACD) Colorado, the NFL Alumni Association, and the Harvard Business School Alumni Board. She previously served on the Boards of Great Western Bank, now First Interstate Bank, Windward Reports; now Apryse; and the Association of Mechanical Engineers (ASME).
The Company also appointed Dr. Benjamin Sanchez in February 2025 as a Scientific Advisor. Dr. Sanchez will help accelerate non-dilutive federal funding and licensing as well as bolster relationships with clinical research organizations seeking alcohol detection testing. Currently Dr. Sanchez serves as an Associate Professor at the University of Illinois Chicago in the Electrical and Computer Engineering as well as Biomedical Engineering departments. Dr. Sanchez received a dual BS in Telecommunication and Electronic Engineering, and his MS and PhD in Electronic Engineering from Universitat Politecnica de Catalunya (UPC), Barcelona, Spain.
"Dr. Sanchez is another strategic asset to our team bringing expertise across wearable bioimpedance technologies, physiological signal processing, and digital health systems" continued SOBRsafe Chairman and CEO David Gandini. "With years of research in biomedical engineering, Benjamin will accelerate the evolution of our alcohol detection platform, while also helping us build critical partnerships across clinical research and federal collaboration."
For more details, please reference the Form 8-K filed with the U.S. Securities and Exchange Commission on May 13, 2025, which can also be found in the Investor Relations of the Company's website.
About SOBRsafe™
Through next-generation alcohol detection technology, we enable trust and empower recovery ... with a human touch. SOBRsafe's advanced transdermal (touch-based) technology detects and reports in real-time the presence of alcohol as emitted through a user's skin - no breath, blood, or urine samples are required. With a powerful backend data platform, SOBRsafe provides passive, dignified screening and monitoring solutions for the behavioral health, family law and consumer markets, and for licensing and integration. To learn more, visit www.sobrsafe.com.
Safe Harbor Statement
Our prospects here at SOBRsafe are subject to uncertainties and risks. This news release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. The Company intends that such forward-looking statements be subject to the safe harbor provided by the foregoing Sections. These forward-looking statements are based largely on the expectations or forecasts of future events, can be affected by inaccurate assumptions, and are subject to various business risks and known and unknown uncertainties, a number of which are beyond the control of management. Therefore, actual results could differ materially from the forward-looking statements contained in this presentation. The Company cannot predict or determine after the fact what factors would cause actual results to differ materially from those indicated by the forward-looking statements or other statements. The reader should consider statements that include the words "believes", "expects", "anticipates", "intends", "estimates", "plans", "projects", "should", or other expressions that are predictions of or indicate future events or trends, to be uncertain and forward-looking. We caution readers not to place undue reliance upon any such forward-looking statements. The Company does not undertake to publicly update or revise forward-looking statements, whether because of new information, future events or otherwise. Additional information respecting factors that could materially affect the Company and its operations are contained in the Company's filings with the SEC which can be found on the SEC's website at www.sec.gov.
Company Contact:
IR@sobrsafe.com
Investor Relations Contact:
Scott Liolios or Taylor Stadeli
Gateway Group
949-574-3860
SOBR@gateway-grp.com
SOURCE: SOBR Safe, Inc.
View the original press release on ACCESS Newswire